Stocks and Investing
Stocks and Investing
Wed, July 30, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, July 29, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, July 28, 2014
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Chris Schott Maintained (TEVA) at Hold with Increased Target to $58 on, Jul 28th, 2014
Chris Schott of JP Morgan, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $56 to $58 on, Jul 28th, 2014.
Chris has made no other calls on TEVA in the last 4 months.
There are 2 other peers that have a rating on TEVA. Out of the 2 peers that are also analyzing TEVA, 1 agrees with Chris's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jacob Hughes of "Wells Fargo" Initiated at Hold on, Wednesday, June 11th, 2014
This is the rating of the analyst that currently disagrees with Chris
- Liav Abraham of "Citigroup" Maintained at Strong Buy with Increased Target to $70 on, Tuesday, April 1st, 2014